subscribeSubscribe
AstraZeneca scraps midphase drugs from $1B buyout, Heptares pact

AstraZeneca scraps midphase drugs from $1B buyout, Heptares pact
N.P. Taylor FIERCEBIOTECH
13 Nov 2021
Share Share
Grunenthal GmbH`s Duzallo (allopurinol / lesinurad) Receives Approval in Europe

Grunenthal GmbH`s Duzallo (allopurinol / lesinurad) Receives Approval in Europe
EMA
24 Aug 2018
Share Share
Blockbuster dreams quashed, Ironwood drops AZ’s $1.3B gout drug disaster

Blockbuster dreams quashed, Ironwood drops AZ’s $1.3B gout drug disaster
John Carroll ENDPTS
07 Aug 2018
Share Share
Ironwood dumps AZ gout drug Zurampic and lays off 125

Ironwood dumps AZ gout drug Zurampic and lays off 125
Carly Helfand FIERCE PHARMA
06 Aug 2018
Share Share
CAR-T therapies leap towards EU approval

CAR-T therapies leap towards EU approval
Selina McKee PHARMATIMES
02 Jul 2018
Share Share
Under pressure, Peter Hecht splits Ironwood into two spinning out R&D operation

Under pressure, Peter Hecht splits Ironwood into two spinning out R&D operation
John Carroll ENDPTS
01 May 2018
Share Share
Ironwood claims FDA OK for former AZ gout drug

Ironwood claims FDA OK for former AZ gout drug
Phil Taylor PMLIV
24 Aug 2017
Share Share
FDA approves Ironwood Pharma`s gout drug

FDA approves Ironwood Pharma`s gout drug
NASDAQ
22 Aug 2017
Share Share
NICE rejects Zurampic for hyperuricaemia in gout patients

NICE rejects Zurampic for hyperuricaemia in gout patients
Selina McKee PHARMA TIMES
10 Jun 2017
Share Share
MoH warns against taking one lot of Brilinta 90 mg for heart attacks and strokes

MoH warns against taking one lot of Brilinta 90 mg for heart attacks and strokes
EMIRATES NEWS AGENCY
05 Jun 2017
Share Share